FDA Drug · D-0255-2026

Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0522-01. Case label: SpecGx LLC, NDC 0406052201, Exp. 2027/03, Lot: 0522J23493

Class II · Ongoing

Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.

Affected lots / codes — check yours against thisLot: 0522J23493, expires: 03/2027.

Recalling firm: SpecGx, LLC, Webster Groves, MO
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: 74,544 bottles
Distribution: Nationwide
Recall initiated: December 16, 2025
Classified: January 7, 2026
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0255-2026%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →